For decades, the medical community has treated the arrival of menopause as the starting gun for conversations about heart disease in women. But new research suggests that by the time a woman reaches her final menstrual period, a critical window for cardiovascular prevention may have already closed.
An analysis of data from the National Health and Nutritional Examination Survey (NHANES) reveals that cardiovascular health during perimenopause—the transitional phase leading up to menopause—may decline more sharply and unexpectedly than previously realized. The findings suggest that the hormonal volatility of this transition creates a high-risk period that often goes unmonitored by clinicians.
The study, published in the Journal of the American Heart Association, utilized the American Heart Association’s “Life’s Essential 8” (LE8) score to track heart health. This metric evaluates eight key factors: diet, physical activity, nicotine exposure, body mass index (BMI), fasting blood glucose, total cholesterol, blood pressure, and sleep.
While heart health generally declines as women age, the researchers found that perimenopausal women were significantly more likely to have poor overall LE8 scores compared to those who had not yet entered the transition. This suggests that the “hormonal storm” of perimenopause may trigger cardiometabolic shifts long before menopause is officially diagnosed.
The Perimenopause Paradox
The study analyzed data from 9,248 women enrolled in NHANES between 2007 and 2020, representing a population of nearly 62 million people. The researchers observed a steady decline in crude median LE8 scores across reproductive stages, but the age-adjusted data told a more nuanced story.
When adjusting for age, perimenopausal women had nearly twice the odds of having a poor overall LE8 score compared to premenopausal women (adjusted OR 1.92). They also showed a higher likelihood of poor lipid scores and poor glucose scores. Surprisingly, the postmenopausal group did not reach the same level of statistical significance in these specific odds, suggesting that the transition itself—rather than just the end state of menopause—is a period of acute vulnerability.
| Menopausal Stage | Median Age | Crude Median LE8 Score |
|---|---|---|
| Premenopausal | 33.9 | 73.3 |
| Perimenopausal | 50.5 | 69.1 |
| Postmenopausal | 59.7 | 63.9 |
Dr. Garima Arora, a physician at the University of Alabama at Birmingham and senior author of the study, notes that this “flips the conventional narrative.” For too long, the focus has been on the postmenopausal woman, while those in the transition are left to navigate unpredictable metabolic changes without targeted screening.
Hormonal Volatility and the ‘Sandwich Generation’
The decline in cardiovascular health during this window is not caused by a simple drop in estrogen, but rather by the erratic fluctuations that characterize perimenopause. These shifts can create an unstable metabolic environment, affecting how the body processes glucose and lipids.
However, Dr. Arora emphasizes that biology is only part of the equation. Women in perimenopause often belong to the “sandwich generation,” simultaneously managing the needs of growing children, aging parents, and demanding careers. This social pressure often manifests as a decline in diet quality—one of the lowest-scoring components across all groups in the study.
The struggle to maintain a heart-healthy diet, such as the DASH (Dietary Approaches to Stop Hypertension) plan, is often a symptom of time poverty rather than a lack of knowledge. By medicalizing these declines solely as “hormonal,” clinicians may overlook the systemic social stressors that compromise a woman’s heart health during her 40s and 50s.
The Hidden Crisis of Sleep Quality
One of the most striking discrepancies in the data involved sleep. On paper, sleep scores remained consistently high across all groups. However, the LE8 metric primarily measures sleep duration—how many hours a woman spends in bed—rather than sleep quality.
Dr. Arora points out that for many perimenopausal women, hours in bed do not equate to restorative rest. Night sweats and fragmented sleep are hallmarks of the transition, yet because they are technically “sleeping” for seven or eight hours, they receive a passing grade on the LE8 scale. This gap in measurement can lead clinicians to believe a patient is healthy when they are actually suffering from chronic exhaustion, which itself is a risk factor for cardiovascular disease.
Clinical Implications: Stop Waiting for the ‘Starting Gun’
The overarching message for healthcare providers is to shift the timeline for cardiovascular intervention. Rather than waiting for the cessation of menses, clinicians are encouraged to begin aggressive primary prevention during the perimenopausal window.
Practical steps for women in their 40s and early 50s include:
- Earlier Screening: Requesting lipid and fasting glucose checks even if periods are still occurring, as irregular cycles do not guarantee cardiovascular protection.
- Nuanced Sleep Discussions: Moving beyond “How many hours do you sleep?” to “How do you actually feel when you wake up?”
- Holistic Diet Counseling: Discussing nutritional challenges through a lens of lifestyle and time management rather than simple compliance.
Dr. Kayle Shapero, an expert at Brown University Health, agrees that optimizing a woman’s cardiometabolic profile before she completes the transition to menopause is the ideal goal, though she acknowledges the practical difficulties of implementing this in standard primary care.
Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.
The next phase of research will require longitudinal studies that move beyond self-reported menstrual history. Researchers are calling for trials that utilize actual hormone measurements—such as estradiol and follicle-stimulating hormone (FSH) levels—to better disentangle the effects of aging from the effects of hormonal fluctuation. Such data will be essential in determining whether targeted interventions during perimenopause can permanently preserve long-term heart health.
Do you feel your cardiovascular health was discussed during your transition to menopause? Share your experience in the comments or share this article with a friend.
